Cargando…
Preventive treatment can reverse cognitive impairment in chronic migraine
OBJECTIVE: To study the impact of chronic migraine (CM) on the cognition and quality of life (QoL) of patients in the interictal period, and to analyse the degree of reversibility of any observed alterations following the use of preventive treatment. BACKGROUND: CM is a highly disabling disease, and...
Autores principales: | González-Mingot, Cristina, Gil-Sánchez, Anna, Canudes-Solans, Marc, Peralta-Moncusi, Silvia, Solana-Moga, Maria José, Brieva-Ruiz, Luis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Milan
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9476561/ https://www.ncbi.nlm.nih.gov/pubmed/36109696 http://dx.doi.org/10.1186/s10194-022-01486-w |
Ejemplares similares
-
Prophylactic treatment can modify vascular risk biomarkers in high-frequency episodic and chronic migraine patients: a pilot study
por: González Mingot, Cristina, et al.
Publicado: (2023) -
Impairment of Mitochondrial Redox Status in Peripheral Lymphocytes of Multiple Sclerosis Patients
por: Gonzalo, Hugo, et al.
Publicado: (2019) -
A prospective study of cellular immune response to booster COVID-19 vaccination in multiple sclerosis patients treated with a broad spectrum of disease-modifying therapies
por: Torres, Pascual, et al.
Publicado: (2023) -
Lipid profile of cerebrospinal fluid in multiple sclerosis patients: a potential tool for diagnosis
por: Nogueras, L., et al.
Publicado: (2019) -
Seroprevalence of SARS-CoV-2 in a Cohort of Patients with Multiple Sclerosis under Disease-Modifying Therapies
por: Sancho-Saldaña, Agustín, et al.
Publicado: (2022)